Overview.
Vitamin B12 deficiency is more common than most people realise — and the standard blood test 'normal range' catches it late. B12 is essential for DNA synthesis, myelin formation (the insulating sheath around nerve fibres), and the methylation reactions that regulate homocysteine. Deficiency progresses through stages: marginal status with subtle symptoms, then frank deficiency with nerve damage that can become irreversible if untreated.
Vitamin B12 (cobalamin) is a water-soluble vitamin obtained exclusively from animal products and fortified foods. It requires a complex, multi-step absorption pathway: stomach acid releases B12 from food, intrinsic factor (IF) — a protein secreted by gastric parietal cells — binds to it, and the B12-IF complex is absorbed in the terminal ileum. Failure at any point in this chain — whether from autoimmune destruction of parietal cells, insufficient stomach acid, malabsorption in the ileum, or dietary insufficiency — leads to deficiency. The liver stores 2–5 mg of B12, enough to last 3–5 years, which is why deficiency develops slowly and may go unnoticed for years.
Prevalence: B12 deficiency is highly prevalent, though estimates vary widely depending on the diagnostic threshold used. Deficiency rates of up to 52% have been observed in vegan populations compared to approximately 1% in omnivores. In the general adult population, subclinical B12 insufficiency (serum B12 below 300–400 pg/mL, where neurological symptoms may appear even with 'normal' lab results) affects a significant minority. Metformin use — the most prescribed type 2 diabetes drug globally — causes B12 malabsorption in approximately 10–30% of users over time.
Medical name: Vitamin B12 Deficiency / Cobalamin Deficiency
Symptoms.
Early warnings
- Fatigue and low energy disproportionate to lifestyle
- Subtle cognitive changes, brain fog, poor concentration
- Mild mood changes, irritability, or low mood
- Tingling or numbness, particularly in hands or feet
- Glossitis (smooth, painful tongue)
- Slightly elevated MCV on CBC without obvious anaemia
Classic symptoms
- Macrocytic anaemia: large, ineffective red blood cells leading to fatigue, pallor, breathlessness
- Peripheral neuropathy: bilateral tingling, numbness, burning in hands and feet
- Subacute combined degeneration of the spinal cord: weakness, balance problems, difficulty walking
- Cognitive impairment, dementia-like symptoms in advanced deficiency
- Depression and mood changes
- Glossitis (red, smooth, swollen tongue)
- Jaundice (mild, from haemolysis of poorly formed red cells)
Progression
B12 deficiency progresses through stages: (1) hepatic stores deplete (no symptoms); (2) low plasma B12, subclinical metabolic changes (MMA and homocysteine begin to rise); (3) early clinical deficiency — neurological symptoms can appear before anaemia; (4) overt deficiency — macrocytic anaemia and progressive neurological damage. Critically, neurological symptoms may precede or occur without anaemia in up to 25% of cases. Neurological damage from prolonged B12 deficiency can be irreversible — early detection and treatment are essential.
Risk factors.
- Strict vegan or vegetarian diet (B12 is found only in animal products)
- Pernicious anaemia (autoimmune destruction of gastric parietal cells, reducing intrinsic factor)
- Atrophic gastritis (chronic stomach inflammation reducing stomach acid and intrinsic factor)
- Metformin use — interferes with B12 absorption in the terminal ileum
- Proton pump inhibitors (PPIs) and H2 blockers — reduce stomach acid needed to release B12 from food
- Gastric or ileal surgery (gastric bypass, Whipple procedure, ileal resection)
- Celiac disease or Crohn's disease affecting the terminal ileum
- Age over 60 — absorption capacity declines with reduced stomach acid and intrinsic factor production
- Excessive alcohol consumption — impairs absorption and storage
- Breastfeeding infants of B12-deficient mothers
Lab interpretation.
Key biomarkers
- Serum Vitamin B12 — < 200 pg/mL confirms deficiency; 200–400 pg/mL is borderline — further testing with MMA is warranted; optimal functional range is often cited as > 400–500 pg/mL (primary)
- MCV (Mean Corpuscular Volume) — > 100 fL (macrocytosis) is a classic finding in moderate-to-severe B12 deficiency; may be normal in early deficiency (primary)
- Homocysteine — Elevated (> 15 µmol/L) in B12 deficiency; sensitive but not specific — also elevated in folate deficiency and renal disease (secondary)
Diagnostic criteria
- Serum B12 < 200 pg/mL (148 pmol/L): deficiency confirmed
- Serum B12 200–400 pg/mL with symptoms: borderline — add methylmalonic acid (MMA) testing
- MMA > 0.4 µmol/L: indicates functional B12 deficiency at the cellular level, even with borderline serum B12
- Elevated homocysteine (> 15 µmol/L) in conjunction with borderline B12 supports deficiency
- Pernicious anaemia: anti-intrinsic factor antibodies (positive in ~50%) and anti-parietal cell antibodies confirm autoimmune aetiology
- CBC: macrocytic anaemia (MCV > 100 fL), hypersegmented neutrophils (5+ lobes in > 5% of neutrophils)
Recommended panels
When & next steps.
When to test
- Fatigue, cognitive changes, or peripheral neuropathy (tingling, numbness in hands or feet) of unclear cause
- Strict vegan or vegetarian diet for more than 2–3 years without reliable supplementation
- Metformin use for more than 1 year — especially at higher doses
- Long-term PPI or H2 blocker use (> 2 years)
- After gastric bypass or other stomach/intestinal surgery
- Diagnosed pernicious anaemia or atrophic gastritis
- Macrocytosis (MCV > 100 fL) on CBC without obvious explanation
- Elevated homocysteine on routine testing
- Pregnancy or planning pregnancy in at-risk groups
- Older adults (over 60) with unexplained fatigue or cognitive decline
If suspected
- Order serum B12, full CBC, folate, and homocysteine
- If serum B12 is borderline (200–400 pg/mL) with symptoms, add methylmalonic acid (MMA)
- If pernicious anaemia is suspected: anti-intrinsic factor antibody and anti-parietal cell antibody
- Review all medications for B12-depleting agents (metformin, PPIs, H2 blockers)
- Do not delay treatment if clinical suspicion is high — wait for confirmatory results only when neurological symptoms are absent and the clinical picture is uncertain
If confirmed
- Identify and address the underlying cause (dietary, malabsorption, medication-induced)
- For malabsorption (pernicious anaemia, post-gastric surgery): B12 injections are required — oral absorption pathway is bypassed
- For dietary deficiency with intact absorption: high-dose oral methylcobalamin 1,000–2,000 mcg/day is as effective as injection
- For metformin-related depletion: oral B12 supplementation 500–1,000 mcg/day; check B12 annually
- Retest B12 and MMA at 3 months after starting treatment to confirm response
- Neurological symptoms may take 3–6 months to improve and may not fully resolve if deficiency was prolonged — early treatment gives the best outcome
FAQs.
My B12 is 250 pg/mL — my doctor says it's 'normal' but I feel terrible. Could I be deficient?
The conventional normal range (typically 200–900 pg/mL) is based on population statistics, not optimal neurological function. Neurological symptoms from B12 insufficiency — fatigue, brain fog, tingling — can occur at levels well above the deficiency cutoff. Most functional medicine practitioners and some academic researchers suggest symptoms may appear below 300–400 pg/mL. If your B12 is 200–400 pg/mL and you have symptoms, ask your doctor about methylmalonic acid (MMA) testing — an elevated MMA confirms functional cellular B12 insufficiency even when serum B12 appears borderline.
Can I just take B12 supplements, or do I need a diagnosis first?
B12 supplementation is safe and inexpensive — there is no known toxicity from high doses. If you are in an at-risk group (vegan, metformin user, PPI user, over 60) and cannot access testing, starting 500–1,000 mcg of methylcobalamin daily is reasonable as preventive supplementation. However, if you have neurological symptoms (tingling, numbness, balance problems), get tested before supplementing — because treatment may mask the lab diagnosis and delay appropriate care. Neurological damage from untreated B12 deficiency can be irreversible.
I have pernicious anaemia. Do I need injections for life?
Historically, lifetime B12 injections were the standard treatment for pernicious anaemia because the absorption mechanism is permanently impaired. However, well-designed studies have demonstrated that very high doses of oral B12 (1,000–2,000 mcg/day) are absorbed in sufficient quantities via passive diffusion in the gut — even without intrinsic factor — to maintain adequate levels in most patients. Some gastroenterology and haematology guidelines now support oral B12 as an alternative to injection in pernicious anaemia, provided compliance is assured and levels are monitored. Discuss the most appropriate route with your doctor.
I'm taking metformin for diabetes. Should I be monitoring my B12?
Yes. Multiple studies confirm that metformin reduces B12 absorption in a dose-dependent and duration-dependent manner — affecting approximately 10–30% of long-term users. The American Diabetes Association (ADA) recommends periodic B12 monitoring in metformin-treated patients, particularly those on higher doses or with longer duration of use. Annual B12 testing is reasonable for anyone on metformin. B12 supplementation at 500–1,000 mcg/day effectively prevents and corrects metformin-related B12 depletion.
What is the difference between methylcobalamin and cyanocobalamin supplements?
Methylcobalamin and adenosylcobalamin are the active, coenzyme forms of B12 used directly in cellular reactions. Cyanocobalamin is a synthetic, stable form that the body must convert to methylcobalamin. Both are effective for most people. Methylcobalamin is preferred by some practitioners because it does not require metabolic conversion and is the form used in the nervous system. For neurological symptoms, some clinicians specifically prefer methylcobalamin. For standard supplementation and most cases of deficiency, either form is appropriate at adequate doses.